Sensus Healthcare (SRTS) Competitors

$3.07 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$3.00 -0.07 (-2.44%)

As of 07/2/2026 07:17 PM Eastern

SRTS vs. INFU, APYX, EMBC, FOCL, and KRMD

Should you buy Sensus Healthcare stock or one of its competitors? MarketBeat compares Sensus Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sensus Healthcare include InfuSystem (INFU), Apyx Medical (APYX), Embecta (EMBC), FocalTherics (FOCL), and KORU Medical Systems (KRMD). These companies are all part of the "medical equipment" industry.

How does Sensus Healthcare compare to InfuSystem?

InfuSystem (NYSE:INFU) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

71.1% of InfuSystem shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 10.8% of InfuSystem shares are owned by company insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

InfuSystem has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market.

InfuSystem currently has a consensus price target of $15.00, indicating a potential upside of 47.64%. Sensus Healthcare has a consensus price target of $6.88, indicating a potential upside of 123.94%. Given Sensus Healthcare's higher probable upside, analysts clearly believe Sensus Healthcare is more favorable than InfuSystem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InfuSystem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

In the previous week, InfuSystem's average media sentiment score of 1.00 beat Sensus Healthcare's score of 0.00 indicating that InfuSystem is being referred to more favorably in the media.

Company	Overall Sentiment
InfuSystem	Positive
Sensus Healthcare	Neutral

InfuSystem has a net margin of 1.12% compared to Sensus Healthcare's net margin of -34.50%. InfuSystem's return on equity of 2.78% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InfuSystem	1.12%	2.78%	1.41%
Sensus Healthcare	-34.50%	-15.79%	-14.02%

InfuSystem has higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InfuSystem	$142.40M	1.44	$870K	$0.38	26.74
Sensus Healthcare	$22.53M	2.24	-$7.72M	-$0.47	N/A

Summary

InfuSystem beats Sensus Healthcare on 12 of the 15 factors compared between the two stocks.

How does Sensus Healthcare compare to Apyx Medical?

Sensus Healthcare (NASDAQ:SRTS) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

Sensus Healthcare presently has a consensus target price of $6.88, indicating a potential upside of 123.94%. Apyx Medical has a consensus target price of $6.50, indicating a potential upside of 51.16%. Given Sensus Healthcare's higher probable upside, equities analysts clearly believe Sensus Healthcare is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, Apyx Medical had 1 more articles in the media than Sensus Healthcare. MarketBeat recorded 1 mentions for Apyx Medical and 0 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 0.00 equaled Apyx Medical'saverage media sentiment score.

Company	Overall Sentiment
Sensus Healthcare	Neutral
Apyx Medical	Neutral

Apyx Medical has a net margin of -16.40% compared to Sensus Healthcare's net margin of -34.50%. Sensus Healthcare's return on equity of -15.79% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-34.50%	-15.79%	-14.02%
Apyx Medical	-16.40%	-88.47%	-14.94%

Sensus Healthcare has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.37, meaning that its share price is 37% more volatile than the broader market.

25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by insiders. Comparatively, 15.9% of Apyx Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Sensus Healthcare has higher earnings, but lower revenue than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$22.53M	2.24	-$7.72M	-$0.47	N/A
Apyx Medical	$52.84M	3.41	-$11.21M	-$0.22	N/A

Summary

Apyx Medical beats Sensus Healthcare on 10 of the 16 factors compared between the two stocks.

How does Sensus Healthcare compare to Embecta?

Sensus Healthcare (NASDAQ:SRTS) and Embecta (NASDAQ:EMBC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability.

Sensus Healthcare currently has a consensus target price of $6.88, suggesting a potential upside of 123.94%. Embecta has a consensus target price of $11.00, suggesting a potential upside of 228.36%. Given Embecta's higher possible upside, analysts plainly believe Embecta is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Embecta	3 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.40

Embecta has higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$22.53M	2.24	-$7.72M	-$0.47	N/A
Embecta	$1.08B	0.18	$95.40M	$1.90	1.76

In the previous week, Embecta had 29 more articles in the media than Sensus Healthcare. MarketBeat recorded 29 mentions for Embecta and 0 mentions for Sensus Healthcare. Embecta's average media sentiment score of 0.08 beat Sensus Healthcare's score of 0.00 indicating that Embecta is being referred to more favorably in the news media.

Company	Overall Sentiment
Sensus Healthcare	Neutral
Embecta	Neutral

Embecta has a net margin of 10.73% compared to Sensus Healthcare's net margin of -34.50%. Sensus Healthcare's return on equity of -15.79% beat Embecta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-34.50%	-15.79%	-14.02%
Embecta	10.73%	-23.96%	14.12%

Sensus Healthcare has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market. Comparatively, Embecta has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market.

25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 93.8% of Embecta shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by insiders. Comparatively, 1.3% of Embecta shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Embecta beats Sensus Healthcare on 10 of the 16 factors compared between the two stocks.

How does Sensus Healthcare compare to FocalTherics?

Sensus Healthcare (NASDAQ:SRTS) and FocalTherics (NASDAQ:FOCL) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

Sensus Healthcare has a net margin of -34.50% compared to FocalTherics' net margin of -41.47%. Sensus Healthcare's return on equity of -15.79% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-34.50%	-15.79%	-14.02%
FocalTherics	-41.47%	-137.61%	-40.62%

Sensus Healthcare presently has a consensus target price of $6.88, suggesting a potential upside of 123.94%. FocalTherics has a consensus target price of $6.00, suggesting a potential upside of 15.83%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, equities analysts plainly believe Sensus Healthcare is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
FocalTherics	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 62.7% of FocalTherics shares are owned by institutional investors. 10.2% of Sensus Healthcare shares are owned by company insiders. Comparatively, 10.1% of FocalTherics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sensus Healthcare has a beta of 1.09, suggesting that its share price is 9% more volatile than the broader market. Comparatively, FocalTherics has a beta of -0.04, suggesting that its share price is 104% less volatile than the broader market.

Sensus Healthcare has higher earnings, but lower revenue than FocalTherics. Sensus Healthcare is trading at a lower price-to-earnings ratio than FocalTherics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$22.53M	2.24	-$7.72M	-$0.47	N/A
FocalTherics	$70.53M	2.75	-$29.25M	-$0.81	N/A

In the previous week, FocalTherics had 2 more articles in the media than Sensus Healthcare. MarketBeat recorded 2 mentions for FocalTherics and 0 mentions for Sensus Healthcare. FocalTherics' average media sentiment score of 0.97 beat Sensus Healthcare's score of 0.00 indicating that FocalTherics is being referred to more favorably in the news media.

Company	Overall Sentiment
Sensus Healthcare	Neutral
FocalTherics	Positive

Summary

Sensus Healthcare beats FocalTherics on 10 of the 16 factors compared between the two stocks.

How does Sensus Healthcare compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

In the previous week, KORU Medical Systems had 2 more articles in the media than Sensus Healthcare. MarketBeat recorded 2 mentions for KORU Medical Systems and 0 mentions for Sensus Healthcare. KORU Medical Systems' average media sentiment score of 0.00 equaled Sensus Healthcare'saverage media sentiment score.

Company	Overall Sentiment
KORU Medical Systems	Neutral
Sensus Healthcare	Neutral

KORU Medical Systems has a net margin of -5.27% compared to Sensus Healthcare's net margin of -34.50%. KORU Medical Systems' return on equity of -13.61% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-5.27%	-13.61%	-8.33%
Sensus Healthcare	-34.50%	-15.79%	-14.02%

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

KORU Medical Systems has higher revenue and earnings than Sensus Healthcare. KORU Medical Systems is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$43.26M	4.77	-$2.64M	-$0.05	N/A
Sensus Healthcare	$22.53M	2.24	-$7.72M	-$0.47	N/A

KORU Medical Systems has a beta of 0.41, suggesting that its share price is 59% less volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.09, suggesting that its share price is 9% more volatile than the broader market.

KORU Medical Systems currently has a consensus price target of $7.25, indicating a potential upside of 61.47%. Sensus Healthcare has a consensus price target of $6.88, indicating a potential upside of 123.94%. Given Sensus Healthcare's higher probable upside, analysts clearly believe Sensus Healthcare is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

KORU Medical Systems beats Sensus Healthcare on 11 of the 15 factors compared between the two stocks.

Get Sensus Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SRTS vs. The Competition

Export

Metric	Sensus Healthcare	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$50.54M	$7.57B	$7.16B	$12.48B
Dividend Yield	N/A	1.32%	2.66%	6.52%
P/E Ratio	-6.53	52.12	28.02	24.70
Price / Sales	2.24	49.46	540.37	99.49
Price / Cash	N/A	26.72	49.26	57.09
Price / Book	1.05	7.48	10.96	6.46
Net Income	-$7.72M	$159.19M	$3.57B	$337.01M
7 Day Performance	0.99%	-0.39%	2.12%	1.69%
1 Month Performance	13.70%	-0.43%	5.25%	3.81%
1 Year Performance	-36.83%	3.14%	33.29%	23.90%

Sensus Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SRTS Sensus Healthcare	3.4019 of 5 stars	$3.07 flat	$6.88 +123.9%	-36.8%	$50.54M	$22.53M	N/A	40	Positive News
INFU InfuSystem	4.2595 of 5 stars	$9.78 -1.1%	$15.00 +53.5%	+64.9%	$197.28M	$142.40M	162.94	410	Positive News
APYX Apyx Medical	2.4237 of 5 stars	$4.70 +0.2%	$6.50 +38.3%	+87.4%	$196.77M	$55.90M	N/A	270
EMBC Embecta	4.5456 of 5 stars	$3.29 -0.8%	$11.00 +234.9%	-67.5%	$194.90M	$1.08B	1.73	1,850	Trending News Gap Up
FOCL FocalTherics	3.047 of 5 stars	$5.14 flat	$6.00 +16.7%	N/A	$192.66M	$74.07M	N/A	230

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SRTS) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sensus Healthcare (SRTS) Competitors

SRTS vs. INFU, APYX, EMBC, FOCL, and KRMD

How does Sensus Healthcare compare to InfuSystem?

Summary

How does Sensus Healthcare compare to Apyx Medical?

Summary

How does Sensus Healthcare compare to Embecta?

Summary

How does Sensus Healthcare compare to FocalTherics?

Summary

How does Sensus Healthcare compare to KORU Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTS vs. The Competition

Sensus Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sensus Healthcare (SRTS) Competitors

SRTS vs. INFU, APYX, EMBC, FOCL, and KRMD

How does Sensus Healthcare compare to InfuSystem?

Do insiders and institutionals have more ownership in INFU or SRTS?

Which has more volatility & risk, INFU or SRTS?

Do analysts prefer INFU or SRTS?

Does the media prefer INFU or SRTS?

Is INFU or SRTS more profitable?

Which has stronger valuation & earnings, INFU or SRTS?

Summary

How does Sensus Healthcare compare to Apyx Medical?

Do analysts rate SRTS or APYX?

Does the media favor SRTS or APYX?

Is SRTS or APYX more profitable?

Which has more volatility & risk, SRTS or APYX?

Do institutionals & insiders hold more shares of SRTS or APYX?

Which has preferable valuation & earnings, SRTS or APYX?

Summary

How does Sensus Healthcare compare to Embecta?

Do analysts recommend SRTS or EMBC?

Which has better valuation and earnings, SRTS or EMBC?

Does the media refer more to SRTS or EMBC?

Is SRTS or EMBC more profitable?

Which has more volatility & risk, SRTS or EMBC?

Do institutionals and insiders have more ownership in SRTS or EMBC?

Summary

How does Sensus Healthcare compare to FocalTherics?

Is SRTS or FOCL more profitable?

Do analysts prefer SRTS or FOCL?

Do institutionals and insiders have more ownership in SRTS or FOCL?

Which has more risk & volatility, SRTS or FOCL?

Which has better earnings & valuation, SRTS or FOCL?

Does the media refer more to SRTS or FOCL?

Summary

How does Sensus Healthcare compare to KORU Medical Systems?

Does the media prefer KRMD or SRTS?

Is KRMD or SRTS more profitable?

Do institutionals & insiders believe in KRMD or SRTS?

Which has stronger earnings and valuation, KRMD or SRTS?

Which has more risk & volatility, KRMD or SRTS?

Do analysts recommend KRMD or SRTS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTS vs. The Competition

Sensus Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools